Kimura S - Search Results

1

Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell lines.

Matsumoto S, Kimura S, Segawa H, Kuroda J, Yuasa T, Sato K, Nogawa M, Tanaka F, Maekawa T, Wada H. Matsumoto S, et al. Among authors: kimura s. Lung Cancer. 2005 Jan;47(1):31-9. doi: 10.1016/j.lungcan.2004.06.003. Lung Cancer. 2005. PMID: 15603852

2

Comprehensive cytogenetic study by spectral karyotyping on blastic natural killer cell leukemia/lymphoma.

Jyoko N, Kuroda J, Kimura S, Kobayashi Y, Yoshikawa T. Jyoko N, et al. Among authors: kimura s. Am J Hematol. 2002 Mar;69(3):234-5. doi: 10.1002/ajh.10064. Am J Hematol. 2002. PMID: 11891818 Free article. No abstract available.

3

Unusual myelodysplastic syndrome with the initial presentation mimicking idiopathic thrombocytopenic purpura.

Kuroda J, Kimura S, Kobayashi Y, Wada K, Uoshima N, Yoshikawa T. Kuroda J, et al. Among authors: kimura s. Acta Haematol. 2002;108(3):139-43. doi: 10.1159/000064703. Acta Haematol. 2002. PMID: 12373085

4

Aplastic anemia evolving into overt myelodysplastic syndrome/acute myeloid leukemia with t(3;5)(p25;q31).

Kawata E, Kuroda J, Kimura S, Kamitsuji Y, Kobayashi Y, Yoshikawa T. Kawata E, et al. Among authors: kimura s. Cancer Genet Cytogenet. 2002 Sep;137(2):91-4. doi: 10.1016/s0165-4608(02)00556-3. Cancer Genet Cytogenet. 2002. PMID: 12393278

5

Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/lymphoma.

Kimura S, Horie A, Hiki Y, Yamamoto C, Suzuki S, Kuroda J, Deguchi M, Kato G, Karasuno T, Hiraoka A, Yoshikawa T, Maekawa T. Kimura S, et al. Blood. 2003 May 15;101(10):4219-21. doi: 10.1182/blood-2002-07-2290. Epub 2003 Jan 23. Blood. 2003. PMID: 12543867 Free article.

6

The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph+ leukemia activity of imatinib mesylate.

Kuroda J, Kimura S, Segawa H, Kobayashi Y, Yoshikawa T, Urasaki Y, Ueda T, Enjo F, Tokuda H, Ottmann OG, Maekawa T. Kuroda J, et al. Among authors: kimura s. Blood. 2003 Sep 15;102(6):2229-35. doi: 10.1182/blood-2003-01-0305. Epub 2003 May 22. Blood. 2003. PMID: 12763930 Free article.

7

p53-independent anti-tumor effects of the nitrogen-containing bisphosphonate zoledronic acid.

Kuroda J, Kimura S, Segawa H, Sato K, Matsumoto S, Nogawa M, Yuasa T, Kobayashi Y, Yoshikawa T, Ottmann OG, Maekawa T. Kuroda J, et al. Among authors: kimura s. Cancer Sci. 2004 Feb;95(2):186-92. doi: 10.1111/j.1349-7006.2004.tb03202.x. Cancer Sci. 2004. PMID: 14965371 Free PMC article.

8

Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell lines.

Kimura S, Kuroda J, Segawa H, Sato K, Nogawa M, Yuasa T, Ottmann OG, Maekawa T. Kimura S, et al. Int J Hematol. 2004 Jan;79(1):37-43. doi: 10.1007/BF02983531. Int J Hematol. 2004. PMID: 14979476

9

[Cell therapy. 1. Donor lymphocyte infusion therapy].

Kuroda J, Kimura S. Kuroda J, et al. Among authors: kimura s. Nihon Naika Gakkai Zasshi. 2004 Jul 10;93(7):1392-7. doi: 10.2169/naika.93.1392. Nihon Naika Gakkai Zasshi. 2004. PMID: 15298276 Japanese. No abstract available.

10

Inhibition of leukemic cell growth by a novel anti-cancer drug (GUT-70) from calophyllum brasiliense that acts by induction of apoptosis.

Kimura S, Ito C, Jyoko N, Segawa H, Kuroda J, Okada M, Adachi S, Nakahata T, Yuasa T, Filho VC, Furukawa H, Maekawa T. Kimura S, et al. Int J Cancer. 2005 Jan 1;113(1):158-65. doi: 10.1002/ijc.20505. Int J Cancer. 2005. PMID: 15386357

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,887 results

Search Page

Filters